Patient demographics for the qPCR bladder cancer samples
. | Normals . | Ta . | T1 . | T2 . | T3-4 . | Superficials . | Invasives . | Tumors . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | 10 | 11 | 32 | 11 | 6 | 43 | 17 | 60 | ||||||||
Mean age (y) | 76.4 | 71.0 | 71.2 | 69.5 | 68.3 | 71.2 | 69.1 | 70.57 | ||||||||
Age range (y) | 68-87 | 62-82 | 42-89 | 56-83 | 46-91 | 42-89 | 46-91 | 42-91 | ||||||||
Sex | ||||||||||||||||
M | 10 | 9 | 25 | 10 | 4 | 34 | 14 | 48 | ||||||||
F | 0 | 2 | 7 | 1 | 2 | 9 | 3 | 12 | ||||||||
Operation | Cystoscopy and biopsy | TURBT | TURBT | TURBT | T3 (5) = TURBT; T4 (1) = CYST | TURBT | TURBT = 16; CYST = 1 | TURBT = 59; CYST = 1 | ||||||||
Adjuvant intravesical therapy | Nil = 4; MMC = 2; BCG = 2; both = 1; N/A = 2 | Nil = 21; MMC = 2; BCG = 6; both = 1; N/A = 2 | Nil = 25; MMC = 4; BCG = 8; both = 2; N/A = 4 | |||||||||||||
Invasive cancer treatment | DXT = 7; CYST = 2; N/A = 1 | DXT = 1; CYST = 2; Nil = 3 | DXT = 8; CYST = 4; Nil = 1; N/A = 1 |
. | Normals . | Ta . | T1 . | T2 . | T3-4 . | Superficials . | Invasives . | Tumors . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number | 10 | 11 | 32 | 11 | 6 | 43 | 17 | 60 | ||||||||
Mean age (y) | 76.4 | 71.0 | 71.2 | 69.5 | 68.3 | 71.2 | 69.1 | 70.57 | ||||||||
Age range (y) | 68-87 | 62-82 | 42-89 | 56-83 | 46-91 | 42-89 | 46-91 | 42-91 | ||||||||
Sex | ||||||||||||||||
M | 10 | 9 | 25 | 10 | 4 | 34 | 14 | 48 | ||||||||
F | 0 | 2 | 7 | 1 | 2 | 9 | 3 | 12 | ||||||||
Operation | Cystoscopy and biopsy | TURBT | TURBT | TURBT | T3 (5) = TURBT; T4 (1) = CYST | TURBT | TURBT = 16; CYST = 1 | TURBT = 59; CYST = 1 | ||||||||
Adjuvant intravesical therapy | Nil = 4; MMC = 2; BCG = 2; both = 1; N/A = 2 | Nil = 21; MMC = 2; BCG = 6; both = 1; N/A = 2 | Nil = 25; MMC = 4; BCG = 8; both = 2; N/A = 4 | |||||||||||||
Invasive cancer treatment | DXT = 7; CYST = 2; N/A = 1 | DXT = 1; CYST = 2; Nil = 3 | DXT = 8; CYST = 4; Nil = 1; N/A = 1 |
Abbreviations: CYST, cystectomy; DXT, radiotherapy; BCG, bacille Calmette Guérin; MMC, mitomycin C; Nil, no further treatment; N/A, not applicable.